Account
News
11.05.2022
Mental Health Awareness Week at Remap

Mental Health Awareness Week is an annual event, taking place between 9th – 15th May this year...

Read more
News
07.04.2022
Annual CSR Report 2022

Introduction Employee wellbeing, our local community and the environment has always been a core valu...

Read more
News
11.03.2021
Asia Pacific Digital Health Insights

Remap Consulting recently attended an ISPOR webinar discussing the digital health ecosystem in APAC ...

Read more
News
07.10.2020
Revisiting the influence of ICER in the US

ICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...

Read more
News
05.09.2019
Pricing and market access launch challenges

We are delighted to say that we have received fabulous feedback, with responses from 15 industry exe...

Read more
News
08.07.2019
Cancer drug receives NHS approval

A targeted drug has been accepted for routine use on the NHS in England for some adults with untreat...

Read more
News
30.04.2019
How pharmacist biosimilar substitution would work

The law provides a legal framework for the automatic substitution of biosimilars at the level of the...

Read more
News
10.04.2019
The Orkambi blame game

The deadlock between Vertex and NHS over the cystic fibrosis drug Orkambi was played out in a parlia...

Read more
News
08.04.2019
UK pharma negotiating choppy seas during Brexit

The ABPI is working closely with the Department of Health and Social Care, NHS England and NICE to e...

Read more
News
02.04.2019
Kymriah - a tale of two indications

NICE was the first EU HTA body to provide their assessment of Kymriah for ALL, publishing their opin...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.